Naoko Niho
Cancer Prevention Division
National Cancer Center Research Institute
Tokyo
Japan
Name/email consistency: high
- Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea. Niho, N., Mutoh, M., Sakano, K., Takahashi, M., Hirano, S., Nukaya, H., Sugimura, T., Wakabayashi, K. Cancer Sci. (2006)
- Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist. Niho, N., Mutoh, M., Kitamura, T., Takahashi, M., Sato, H., Yamamoto, H., Maruyama, T., Ohuchida, S., Sugimura, T., Wakabayashi, K. Cancer Sci. (2005)
- Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Niho, N., Takahashi, M., Kitamura, T., Shoji, Y., Itoh, M., Noda, T., Sugimura, T., Wakabayashi, K. Cancer Res. (2003)
- Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPAR gamma ligand. Niho, N., Takahashi, M., Shoji, Y., Takeuchi, Y., Matsubara, S., Sugimura, T., Wakabayashi, K. Cancer Sci. (2003)